School of Medicine
Showing 81-90 of 247 Results
-
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
Researcher Cardiovascular Medicine, Stanford University
Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University
Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Sneha Shah Jain MD, MBA
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sneha S. Jain is a Clinical Assistant Professor of Medicine in the Division of Cardiovascular Medicine at Stanford University, where she specializes in general cardiovascular medicine and preventive cardiology. She co-founded and is the director of GUIDE-AI, which focuses on the development, responsible deployment, and pragmatic evaluation of AI tools to augment healthcare delivery and improve patient outcomes across the healthcare enterprise.
Dr. Jain completed her undergraduate studies in Economics at Duke University, graduating with distinction, before earning her MD from the Johns Hopkins School of Medicine and her MBA from Harvard Business School. She completed internal medicine residency training at Columbia/NewYork-Presbyterian, and fellowship training in cardiovascular medicine at Stanford University.
Dr. Jain serves as an Expert AI Consultant for the Journal of the American College of Cardiology, a member of the AHA Expert Panel for the AI Validation Lab, and Co-Director of the Cross-Sectional Artificial Intelligence Working Group at the American College of Cardiology, where she also serves on the Healthcare Innovation Council. -
David Jimenez-Morales
Sr Research Engineer, Medicine - Med/Cardiovascular Medicine
Current Role at StanfordBioinformatics Lead & Senior Research Scientist Department of Medicine, Division of Cardiovascular Medicine
At Stanford, Dr. Jimenez-Morales owns and leads organization-wide data initiatives, most notably for the Molecular Transducers of Physical Activity Consortium (MoTrPAC) and COVID-omics projects. He coordinates a multidisciplinary team of analysts and researchers, overseeing the data engineering and analysis for complex multi-omics, multi-tissue in-vivo, and clinical studies.
A key aspect of his role involves developing innovative, scalable computational infrastructure from the ground up. This includes engineering comprehensive data injection and quality control systems, and implementing FAIR data science principles. He also serves as a mentor to staff, postdocs, and graduate students, cultivating a collaborative and highly productive research environment. -
Roy Mattathu John, MD, PhD, FRCP
Clinical Professor, Medicine - Cardiovascular Medicine
BioDr. John is a fellowship-trained cardiologist with more than 25 years of experience. He is a clinical professor in the Department of Medicine at Stanford University School of Medicine.
He originally earned board certification in clinical cardiac electrophysiology in 1996 and has continued to recertify. He also has earned board certification in cardiovascular disease and internal medicine.
Dr. John diagnoses and manages all forms of cardiac arrhythmias including atrial fibrillation and ventricular arrhythmias. His special interests include catheter ablation for SVT, atrial arrhythmias, pacemaker and defibrillator implants, and lead extraction.
He has conducted extensive research. He has participated in large multi-center clinical trials, including over 30 studies as a primary investigator of drugs, devices, and ablation techniques. He helped pioneer a new way to manage scar-related ventricular tachycardia. He also helped develop innovations in cardiac pacemaker technology.
Dr. John has authored over 200 publications that include 126 original research papers. They have appeared in reputed journals such as the New England Journal of Medicine, Circulation, Lancet, Journal of the American College of Cardiology, European Heart Journal, Heart Rhythm, Journal of Cardiovascular Electrophysiology, and many more. Topics have included innovative, new techniques and technologies for the treatment of supraventricular arrhythmias, atrial fibrillation, ventricular tachycardia, catheter ablation, lead extraction, cardiac pacing, and defibrillation.
He was a member of the editorial board for Circulation and is currently on the editorial board of the publications Heart Rhythm Journal, Arrhythmia and Electrophysiology, Journal of Cardiac Electrophysiology, and Journal of Innovations in Cardiac Rhythm Management.
Dr. John also has written several chapters for medical textbooks such as Harrison’s Principles of Internal Medicine, Zipes Textbook on Cardiac Electrophysiology - Cell to Bedside, Conn’s Current Therapy, Electrical Disorders of the Heart, Cardiac Mapping, and many more.
He has made invited presentations to his peers at scientific sessions of the Heart Rhythm Society, American Heart Association, American College of Cardiology, and Heart Failure Society. He has delivered more than 60 national and international lectures. Subjects include cardiac pacing, defibrillation, heart failure, and arrhythmia management including catheter ablation for arrhythmias.
Dr. John is a fellow of the American College of Cardiology, Heart Rhythm Society, and Royal College of Physicians of London.
He has volunteered his time and expertise to provide free cardiac care to underserved patients in Bolivia, India, and Kenya. -
Neil M. Kalwani, MD, MPP
Clinical Instructor, Medicine - Cardiovascular Medicine
BioDr. Neil M. Kalwani is a board-certified, fellowship-trained cardiologist with Stanford Health Care. He is also a clinical instructor in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine. In addition, he serves as director of preventive cardiology at the Veterans Affairs (VA) Palo Alto Health Care System.
Dr. Kalwani specializes in general and preventive cardiology care. He has expertise in treating high cholesterol and other risk factors to prevent and stop the progression of coronary artery disease and other forms of atherosclerosis. He provides compassionate care centered around his patients' goals and prioritizes effective therapies based on the latest evidence to improve heart health and overall well-being.
Dr. Kalwani’s research focuses on innovations in care delivery designed to improve the value of care for people living with cardiovascular disease. He is especially interested in telemedicine and its impact on cardiology care, including on quality of care, practice patterns, and access. He has also investigated clinical decision support for cardiac testing, measurement of patient-reported outcomes for heart disease, and lipoprotein (a) testing patterns.
Dr. Kalwani has published his research in many peer-reviewed journals, including Circulation, the American Heart Journal, the American Journal of Preventive Cardiology, and the Journal of Telemedicine and Telecare. He has also presented his research at the American College of Cardiology (ACC) and American Heart Association (AHA) Scientific Sessions. His presentations have covered topics ranging from telemedicine’s effect on care delivery to the impact of physician productivity assessment on medical center performance.
Dr. Kalwani is a member of the ACC, AHA, and American Society of Echocardiography (ASE). -
Guson Kang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Kang is an interventional cardiologist who specializes in the treatment of structural heart disease. He is an expert in complex coronary interventions, transcatheter aortic, mitral, and tricuspid valve replacements, transcatheter mitral and tricuspid valve repair, left atrial appendage occlusion, PFO/septal defect closure, alcohol septal ablation, paravalvular leak closure, balloon pulmonary angioplasty, and pulmonary vein stenting.
A Bay Area native, he graduated from Stanford University and obtained his medical degree at Yale University. He came back to Stanford to train in internal medicine, cardiology, and interventional cardiology before completing an advanced structural interventions fellowship at Ford Hospital. -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html
